Laboratory

Highlight on the DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay

Clinical

Discovers our solutions

A new “Door To Door” service provided by ABL company !

Jul 15, 2021

For more information please contact us at the following email address: contact@ablsa.com
Read more
Turnkey Solutions for SARS-CoV-2 Variants Screening (Delta, Lambda, Epsilon…)

Jul 13, 2021

For more information please contact us at the following email address: contact@ablsa.com
Read more
LNS ET ABL DÉVELOPPENT UNE SOLUTION DE DIAGNOSTIC COMMUNE DANS LA LUTTE CONTRE LA COVID-19

Jul 06, 2021

Le Laboratoire national de santé (LNS) et Advanced Biological Laboratories (ABL) s’associent dans la lutte contre la COVID-19. A cette fin, les deux laboratoires ont signé un accord qui prévoit le développement d’une solution de diagnostic intégrée. Le projet, appelé INNOV-COV-ID, est cofinancé par…

Autorisation de l’ANSM à mettre sur le marché le réactif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations

Jun 18, 2021

Autorisation de mise sur le marché du dispositif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations Nous avons le plaisir d’annoncer la disponibilité immédiate* du dispositif médical UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations, permettant, par amplification gén…
ABL Announces Distribution Agreement with AN BINH MEDICAL in Vietnam

May 31, 2021

Advanced Biological Laboratories (ABL) S.A. and An Binh Medical are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Vietnam. See current channel partners.
Read more
Advanced Biological Laboratories Receives CE-IVD Registration for its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the First CE-IVD Marked Kit for SARS-CoV-2 genotyping clinical applications

May 25, 2021

SARS-CoV-2 Genotyping using Next Generation Sequencing (NGS) Now Suited to Small, Medium and High-throughput Clinical Settings. Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the first in-vitro diagnostics kit…
Read more